Skip to main content
2025 DC/CSEM Professional Conference Main banner
On-Demand

CCE Stream

DCS19 - Type 2 Diabetes Remission - Evidence, Impact, and Future Directions

Saturday, November 29, 2025
10:45 - 12:00 Toronto
Location: Room 201 A/B/C/D/E/F

    Speaker(s)

  • Megan Racey, PhD (she/her/hers)

    Research Coordinator
    McMaster University
    Hamilton, Ontario, Canada

    Disclosure(s): I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose

  • Diana Sherifali, RN, PhD, CDE (she/her/hers)

    Professor
    McMaster University
    McMaster University
    Hamilton, Ontario, Canada

    Disclosure(s): I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose

  • Brian J. McKenna, MD, MSc, CCFP (he/him/his)

    Lead Physician
    Hamilton Family Health Team
    Hamilton, Ontario, Canada

    Disclosure(s): I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose

  • Mark Ewer, MSW (he/him/his)

    Patient Partner
    N/A
    Hamilton, Ontario, Canada

    Disclosure(s): I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose

    • Moderator(s)

  • LS

    Lindsay Sawatsky, RD CDE (she/her/hers)

    Registered Dietitian
    Children's Hospital Winnipeg Manitoba
    Winnipeg, Manitoba, Canada

    Disclosure(s): Insulet Canada: Independent Contractor (Ongoing)

  • Sonja M. Reichert, MD, MSc, FCFP, ABOM Diplomat, Co-Chair: Clinical Care and Education Stream (she/her/hers)

    Associate Professor, MD
    Western University
    Western University
    London, Ontario, Canada

    Disclosure(s): Abbott: Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); American Diabetes Association: Independent Contractor (Terminated, September 1, 2025); Bausch: Advisory Board (Terminated, November 1, 2024); Bayer: Advisory Board (Terminated, June 9, 2025); Center for Effective Practise: Employment (Terminated, January 1, 2025); CPD Network Association: Speaker/Honoraria (Terminated, September 23, 2025); Diabetes Canada: Committee/Planning Member (Ongoing); Eisai: Advisory Board (Terminated, November 20, 2024); Eli Lilly: Advisory Board (Ongoing), Grant/Research Support (Ongoing); Embecta: Advisory Board (Terminated, November 21, 2024); Novartis: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Novo Nordisk: Advisory Board (Terminated, March 1, 2025), Committee/Planning Member (Terminated, March 1, 2025), Grant/Research Support (Terminated, March 1, 2025), Speaker/Honoraria (Terminated, March 1, 2025); Sanofi: Speaker/Honoraria (Terminated, June 4, 2025); Western University: Employment (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Disclosure(s):
Megan Racey, PhD: I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose
Diana Sherifali, RN, PhD, CDE: I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose
Brian J. McKenna, MD, MSc, CCFP: I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose
Mark Ewer, MSW: I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose
Lindsay Sawatsky, RD CDE: Insulet Canada: Independent Contractor (Ongoing)
Sonja M. Reichert, MD, MSc, FCFP, ABOM Diplomat, Co-Chair: Clinical Care and Education Stream: Abbott: Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); American Diabetes Association: Independent Contractor (Terminated, September 1, 2025); Bausch: Advisory Board (Terminated, November 1, 2024); Bayer: Advisory Board (Terminated, June 9, 2025); Center for Effective Practise: Employment (Terminated, January 1, 2025); CPD Network Association: Speaker/Honoraria (Terminated, September 23, 2025); Diabetes Canada: Committee/Planning Member (Ongoing); Eisai: Advisory Board (Terminated, November 20, 2024); Eli Lilly: Advisory Board (Ongoing), Grant/Research Support (Ongoing); Embecta: Advisory Board (Terminated, November 21, 2024); Novartis: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Novo Nordisk: Advisory Board (Terminated, March 1, 2025), Committee/Planning Member (Terminated, March 1, 2025), Grant/Research Support (Terminated, March 1, 2025), Speaker/Honoraria (Terminated, March 1, 2025); Sanofi: Speaker/Honoraria (Terminated, June 4, 2025); Western University: Employment (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
Learning Objectives: This session will:
1. Review the latest evidence for non-pharmacotherapy and pharmacotherapy (multimodal) interventions for type 2 diabetes remission.
2. Help understand the lived experience of individuals living with type 2 diabetes and participating in a type 2 diabetes remission program.
3. Describe the barriers and challenges to implementing type 2 diabetes remission in primary care.